COMMUNIQUÉS West-GlobeNewswire

Aeglea BioTherapeutics to Present at 21st Annual H.C. Wainwright Global Investment Conference
05/09/2019
Live Webcast Scheduled for 5:30 p.m. ET on Monday, September 9 AUSTIN, Texas, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that engineers next- [...]
Aclaris Therapeutics Announces New Strategic Direction
05/09/2019
Completion of Strategic Review and Refocusing of Resources on Immuno-Inflammatory Development Pipeline Actively Seeking a Commercialization Partner for RHOFADE® (oxymetazoline hydrochloride) cream, 1% Actively Exploring [...]
INmune Bio to Present at the H.C. Wainwright 21st Annual Healthcare Conference on Tuesday, September 10th at 2:10 p.m. ET
05/09/2019
LA JOLLA, Calif., Sept. 05, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB ), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, is pleased [...]
Fortress Biotech to Present at September 2019 Investor Conferences
05/09/2019
NEW YORK, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential marketed and [...]
Genprex (GNPX) Featured in NetworkNewsWire Publication Summarizing Gene Therapy Treatment for Lung Cancer
05/09/2019
NEW YORK, Sept. 05, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — Genprex Inc. (NASDAQ: GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing [...]
Cronos Group Inc. Closes Redwood Holding Group Acquisition
05/09/2019
TORONTO, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”) today announced that it has closed its previously announced acquisition of four Redwood [...]
Better Choice Company Announces Marketing Partnership with iHeartMedia
05/09/2019
NEW YORK, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (OTCQB: BTTR) (the “Company” or “Better Choice”), an animal health and wellness CBD company, today announced a new media partnership with [...]
American BriVision Announces Strategic Collaboration with BioLite Japan
05/09/2019
Collaboration combines BioLite Japan’s early-stage discovery capabilities with the Company’s clinical trial expertise BioLite Japan’s expertise in academic and medical community in Japan and APAC region brings new [...]
Catalyst Biosciences to Present at the 2019 ASBMB Symposium on Serine Proteases in Pericellular Proteolysis and Signaling Conference
05/09/2019
SOUTH SAN FRANCISCO, Calif., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced an oral presentation at the 2019 American Society for Biochemistry and Molecular Biology (ASBMB [...]
VBI Vaccines to Present at the H.C. Wainwright 21st Annual Global Investment Conference
05/09/2019
CAMBRIDGE, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, [...]
Alimera Sciences Board of Directors Approves Reverse Stock Split and 10b5-1 Stock Purchase Plan for U.S. Executive Management
05/09/2019
ATLANTA, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal [...]
GBT Announces U.S. Food and Drug Administration Acceptance of New Drug Application and Priority Review for Voxelotor for the Treatment of Sickle Cell Disease
05/09/2019
Priority Review Shortens FDA Review Time to Six Months from Standard 10 Months NDA Supported by Data from Phase 3 HOPE Study, which Demonstrated Statistically Significant and Sustained Improvements in Hemoglobin with [...]
Dr. Henry Ji to Participate in Multiple Investment Conferences in September 2019 to Provide Corporate Updates
05/09/2019
SAN DIEGO, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), announced today that Dr. Henry Ji, Chairman and CEO, will participate in multiple investment conferences in September [...]
REPEAT: AgraFlora Organics Awarded YuShop Global Listing; To Fulfill Chinese Pre-Orders with Premium Hemp-Derived Cosmetics SKUs Via One of China’s Premier Cross-Border Lifestyle/E-Commerce Platform
05/09/2019
VANCOUVER, British Columbia, Sept. 05, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF ), a growth oriented and diversified [...]
BioSig‘s Subsidiary NeuroClear Technologies, Inc. Raises $3.7 million
05/09/2019
The Company to develop solutions to advance bioelectronic medicine Westport, CT, Sept. 05, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical [...]
Auxly Announces Receipt of Cannabis Research Licence to KGK Science
05/09/2019
VANCOUVER, British Columbia, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (“ Auxly ” or the “ Company ”) today announced that its wholly-owned subsidiary, KGK Science Inc. (“ KGK ”), has [...]
European Research Initiative Adopts PacBio Sequel II System to Solve Rare Diseases
05/09/2019
SOLVE-RD program will sequence more than 500 human genomes with SMRT Sequencing MENLO PARK, Calif., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high- [...]
KemPharm to Present at the 21st Annual Global Investment Conference, Sponsored By H.C. Wainwright & Co.
05/09/2019
CELEBRATION, Fla., Sept. 05, 2019 (GLOBE NEWSWIRE) -- KemPharm, Inc. (Nasdaq:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced that its president [...]
Wave Life Sciences Expands Board of Directors with Three New Appointments
05/09/2019
New independent directors bring deep expertise in drug development, commercial operations and government affairs CAMBRIDGE, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical- [...]

Pages